Not all patients respond equally to GLP-1 agonist therapy, and identifying optimal candidates requires considering multiple factors, including baseline weight, comorbidities, and individual tolerance profiles
If you want or need something beyond compounded injectable semaglutide or tirzepatide, you will need to look elsewhere
Adding an extra week or two at each dose level allows the body more time to adapt
Communication Expectations You deserve straightforward answers
The peptide was originally developed by Metabolic Pharmaceuticals in Australia
Dos: Store the vial in a clean, dry area to avoid exposure to moisture, dirt, or bacteria